

TELA Bio is suing Becton Dickinson for allegedly abusing its monopoly power in the hernia mesh market to limit competition and harm patients.
You can purchase shares of TELA Bio (NASDAQ:TELA) through any online brokerage.
Other companies in TELA Bio’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
TELA Bio has a consensus price target of $4.50.
The stock price for TELA Bio (NASDAQ: TELA) is $1.173 last updated October 21, 2026 at 9:15 AM EDT.
There are no upcoming dividends for TELA Bio.
TELA Bio does not have any upcoming earnings scheduled.
There is no upcoming split for TELA Bio.
TELA Bio is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product...